文献速递艾滋病与性传播感染

炎症生物标志物与人类免疫缺陷病毒感染肯尼亚人的临床评分指数相关

Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans.
PubMed 文献 · J Infect Dis · 2019-01-01

在肯尼亚304名参与者中开展的横断面研究,比较HIV感染与未感染者28种炎症生物标志物水平,并评估其与VACS指数、FIB-4评分和Framingham风险评分的相关性。病毒学抑制的HIV感染者多种炎症标志物水平高于未感染者,部分标志物与预测发病和死亡的评分指数相关。

要点

  • 病毒学抑制的HIV感染者CCL5、CXCL10、FABP2、FASLG、MMP1、MMP7、sCD14和sCD163水平高于未感染者,MMP9较低(P < .01)。
  • CD4+/HLA-DR+CD38+、sCD14和sCD163与VACS指数相关。
  • FABP2与FIB-4评分正相关,MMP1和MMP2与FIB-4评分负相关。

核心结论

  • 接受抗逆转录病毒治疗且病毒学控制良好的HIV感染者与未感染者之间存在生物标志物水平差异。
  • 部分生物标志物与预测发病和死亡的评分指数相关,可能作为预后指标并指导治疗开发。

研究设计与样本

  • 横断面研究,使用多变量线性回归比较HIV感染与未感染参与者的28种炎症生物标志物水平。
  • 分析了304名肯尼亚人的血浆样本。
  • 评估生物标志物与VACS指数、FIB-4评分和Framingham风险评分的相关性。

主要发现

  • 与HIV未感染者相比,病毒学抑制的HIV感染者CCL5、CXCL10、FABP2、FASLG、MMP1、MMP7、sCD14和sCD163水平较高,MMP9较低(P < .01)。
  • CD4+/HLA-DR+CD38+(ρ = 0.32;P < .001)、sCD14(ρ = 0.25;P = .004)和sCD163(ρ = 0.24;P = .006)与VACS指数相关。
  • FABP2与FIB-4评分正相关(ρ = 0.29;P = .002),MMP1(ρ = -.32;P < .001)和MMP2(ρ = -0.28;P = .002)与FIB-4评分负相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In high-income countries, inflammation has been associated with increased morbidity and mortality in human immunodeficiency virus (HIV)-infected individuals despite treatment with antiretroviral therapy (ART). However, these findings may not be generalizable to low-income settings. METHODS: In this cross-sectional study, multivariable linear regression was used to compare 28 inflammatory biomarker levels in HIV-infected and -uninfected participants. Correlations between biomarkers and Veterans Aging Cohort Study (VACS) index, Fibrosis-4 (FIB-4) score, and Framingham risk score were assessed. RESULTS: Plasma samples from 304 Kenyans were analyzed. Compared to HIV-uninfected controls, virologically suppressed HIV-infected participants had higher levels of CCL5, CXCL10, fatty acid binding protein (FABP) 2, fas ligand (FASLG), matrix metalloproteinase (MMP) 1, MMP7, soluble CD14 (sCD14), and soluble CD163 (sCD163) and lower MMP9 (P < .01). CD4+/HLA-DR+CD38+ (ρ = 0.32; P < .001), sCD14 (ρ = 0.25; P = .004), and sCD163 (ρ = 0.24; P = .006) were correlated with the VACS index. FABP2 was positively correlated (ρ = 0.29; P = .002), whereas MMP1 (ρ = -.32; P < .001) and MMP2 (ρ = -0.28; P = .002) were inversely correlated with the FIB-4 score. CONCLUSIONS: Differences in biomarker levels exist between well-controlled HIV-infected participants on ART and uninfected controls. Some biomarkers are correlated to scoring indices predictive of morbidity and mortality. These biomarkers could serve as prognostic indicators and inform therapeutic development.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Letizia A, Eller MA, Polyak C, et al. Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans. J Infect Dis. 2019. PMID: 30165548. doi:10.1093/infdis/jiy509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。